The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / June / How Zealand Pharma Is Scaling Quality Without Complexity
Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Standards & Regulation Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

How connected quality systems can help growing biotechs remain agile.

06/29/2026 0 min read Video

Share

As biotech companies grow, so does the complexity of their quality processes. How can teams expand without creating disconnected systems, duplicated work, and barriers for users?

Kamilla Vagtborg, Director and Head of Quality Systems at Zealand Pharma, explains how bringing documents, training, quality processes, and validation into one ecosystem can improve transparency and make information easier to navigate. She also discusses the value of investing in the right infrastructure early while keeping systems simple and adaptable as the organization evolves.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Who Funds Biotech Shapes What Gets Built
Development & Clinical Interviews Business & Trends
Who Funds Biotech Shapes What Gets Built

November 4, 2026

9 min read

Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health

Putting Patients in Control of Self-Injection
Drug Delivery Interviews
Putting Patients in Control of Self-Injection

November 4, 2026

5 min read

West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence

What Will It Take to Control Continuous Biomanufacturing
Bioprocessing Biopharma Research News
What Will It Take to Control Continuous Biomanufacturing?

November 2, 2026

2 min read

Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification

The Challenge of Scaling Cell and Gene Therapy
Cell & Gene Supply Chain Interviews
The Challenge of Scaling Cell and Gene Therapy

October 30, 2026

5 min read

Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: